Your session is about to expire
← Back to Search
Avatar Therapy vs Supportive Care for Cannabis Use in Psychotic Disorders (AC2 Trial)
N/A
Recruiting
Led By Stephane Potvin, PhD
Research Sponsored by Ciusss de L'Est de l'Île de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
Awards & highlights
AC2 Trial Summary
This trial will compare two interventions to reduce cannabis use in people with psychotic disorders to see which works better. Results will show if it reduces cannabis use, cannabis use disorder severity, and improves quality of life.
Who is the study for?
This trial is for adults over 18 with schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic symptoms who also have a cannabis use problem. They must not be currently treated for other substance use disorders, detoxing from cannabis, have neurological issues or severe physical illnesses.Check my eligibility
What is being tested?
The study is testing if an 'Avatar Intervention' is more effective than standard supportive care in helping people with psychotic disorders reduce their cannabis use. Participants are randomly assigned to one of the two interventions without knowing which one they're getting.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, side effects may include emotional discomfort or distress related to discussing personal issues and confronting cannabis use habits.
AC2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in cannabis use (Timeline Follow-Back)
Secondary outcome measures
Change in quality of life(Quality of Life Enjoyment and Satisfaction Questionnaire - QLESQ-SF & Quality of Life Scale - QLS)
Change in the severity of the cannabis use disorder (Cannabis Use Problems Identification Test - CUPIT)
AC2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Avatar InterventionExperimental Treatment1 Intervention
The Avatar Intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use with the use of virtual reality and avatars.
Group II: Addiction supportive interventionActive Control1 Intervention
The Addiction supportive intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,617 Total Patients Enrolled
4 Trials studying Psychosis
715 Patients Enrolled for Psychosis
Ciusss de L'Est de l'Île de MontréalLead Sponsor
70 Previous Clinical Trials
5,410 Total Patients Enrolled
Robert-Paul Juster, PhDStudy ChairUniversity of Montreal, Institut universitaire en santé mentale de Montréal
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a severe and unstable illness.I am unable to give consent by myself.I am over 18 and diagnosed with moderate to severe cannabis use disorder.I have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic symptoms.I have a neurological disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Addiction supportive intervention
- Group 2: Avatar Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings available to join this scientific experiment?
"According to clinicaltrials.gov, the initial posting for this particular study was on January 1st 2023 and has since been concluded; however, 1288 other medical trials are still actively recruiting candidates."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger